Financials

  • Market Capitalization 8.45 M
  • Employee 8
  • Founded 2017
  • CEO N/A
  • Website www.cnspharma.com
  • Headquarter Nevada, United States
  • FIGI BBG00PM24T16
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.26
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4799
TRAW
Traws Pharma, Inc. - Common Stock
0.59 USD0.00%+1.72%+25.53%-55.97%9.07 M USD
4810
XCUR
Exicure, Inc. - Common Stock
1.31 USD+1.55%+13.91%-13.82%-75.19%8.58 M USD
4817
SNGX
Soligenix, Inc. - Common Stock
0.38 USD0.00%-7.32%0.00%-66.37%8.27 M USD
4830
ALZN
Alzamend Neuro, Inc. - Common Stock
1.60 USD-3.61%+4.58%+24.03%-34.96%7.67 M USD

Noticias